Cargando…
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
The world is in need of next-generation COVID-19 vaccines. Although first-generation injectable COVID-19 vaccines continue to be critical tools in controlling the current global health crisis, continuous emergence of SARS-CoV-2 variants of concern has eroded the efficacy of these vaccines, leading t...
Autores principales: | Afkhami, Sam, Kang, Alisha, Jeyanathan, Vidthiya, Xing, Zhou, Jeyanathan, Mangalakumari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172971/ https://www.ncbi.nlm.nih.gov/pubmed/37276833 http://dx.doi.org/10.1016/j.coviro.2023.101334 |
Ejemplares similares
-
Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2022) -
Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2023) -
Expression and role of VLA-1 in resident memory CD8 T cell responses to respiratory mucosal viral-vectored immunization against tuberculosis
por: Haddadi, Siamak, et al.
Publicado: (2017) -
Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
por: Lai, Rocky, et al.
Publicado: (2015) -
COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
por: Singh, Ramandeep, et al.
Publicado: (2021)